Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.36 USD | -3.37% | +0.69% | +42.00% |
05-02 | Transcript : Kura Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Kura Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.00% | 1.61B | |
+3.72% | 106B | |
+7.02% | 23.47B | |
-15.04% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-9.55% | 16.78B | |
+5.87% | 14.41B | |
+34.71% | 12.86B | |
+313.89% | 8.78B |
- Stock Market
- Equities
- KURA Stock
- News Kura Oncology, Inc.
- Kura Oncology : HC Wainwright Adjusts Kura Oncology's Price Target to $43 from $45, Keeps Buy Rating